Education
About Us
Working with TipRanks
Follow Us
Biosig Technologies (BSGM)
:BSGM
BSGM Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.23 - $14.11
Previous CloseN/A
Volume81.57K
Average Volume (3M)930.89K
Market Cap
$221.15M
Enterprise Value$8.96M
Total Cash (Recent Filing)$2.82M
Total Debt (Recent Filing)$15.00K
Price to Earnings (P/E)―
Beta1.04
Next Earnings
May 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding35,270,943
10 Day Avg. Volume1,124,504
30 Day Avg. Volume930,892
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.04
Enterprise Value/Revenue689.59
Enterprise Value/Gross Profit-498.04
Enterprise Value/Ebitda-0.32
Forecast
1Y Price Target
$10.00Price Target Upside59.49% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Bulls Say, Bears Say
Bulls Say
AcquisitionThe acquisition of Streamex Exchange Corp. is seen as a move to bridge the gap between traditional finance and the digital economy, enhancing liquidity, accessibility, and efficiency.
Market OpportunityStreamex's focus on real-world asset tokenization in the commodities space presents a market opportunity believed to have a billion dollars market potential.
ValuationThe current valuation of the company is considered attractive, with a significant upside potential from the current share price, leading to a raised 12-month price target.
Bears Say
Financial StabilityThe company has ~$0 in cash and ~$0 million in debt and needs to raise new capital soon if it wants to resume business.
GuidanceThe company did not provide forward guidance.
ReorganizationThe company announced a major reorganization in which it terminated a significant number of its employees and substantially reduced business operations due to lack of capital.
BioSig Technologies News
BSGM FAQ
What was Biosig Technologies’s price range in the past 12 months?
Biosig Technologies lowest stock price was $0.23 and its highest was $14.11 in the past 12 months.
What is Biosig Technologies’s market cap?
Biosig Technologies’s market cap is $221.15M.
When is Biosig Technologies’s upcoming earnings report date?
Biosig Technologies’s upcoming earnings report date is May 18, 2026 which is in 242 days.
How were Biosig Technologies’s earnings last quarter?
Biosig Technologies released its earnings results on May 19, 2025. The company reported -$0.14 earnings per share for the quarter, missing the consensus estimate of -$0.05 by -$0.09.
Is Biosig Technologies overvalued?
According to Wall Street analysts Biosig Technologies’s price is currently Undervalued.
Does Biosig Technologies pay dividends?
Biosig Technologies does not currently pay dividends.
What is Biosig Technologies’s EPS estimate?
Biosig Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biosig Technologies have?
Biosig Technologies has 35,270,943 shares outstanding.
What happened to Biosig Technologies’s price movement after its last earnings report?
Biosig Technologies reported an EPS of -$0.14 in its last earnings report, missing expectations of -$0.05. Following the earnings report the stock price went up 8.812%.
Which hedge fund is a major shareholder of Biosig Technologies?
Currently, no hedge funds are holding shares in BSGM
BioSig Technologies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.00 (59.49% Upside)
$10.00 (59.49% Upside)
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.2%
Last 30 Days ▲ 1.1%
Last 30 Days ▲ 1.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
1302.68%
12-Months-Change
Fundamentals
Return on Equity
5400.35%
Trailing 12-Months
Asset Growth
3431.41%
Trailing 12-Months
Company Description
Biosig Technologies
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
Technical Analysis
Accelerate Diagnostics
―
Co-Diagnostics
―
PAVmed
―
Vivos Therapeutics
―
Adagio Medical Holdings
―
Ownership Overview
13.33% Insiders
0.58% Mutual Funds
44.17% Other Institutional Investors
39.60% Public Companies and
Individual Investors